Enveric Biosciences (ENVB) reported a net loss attributable to stockholders of $3.0 million, or $0.76 per basic and diluted share, for the second quarter ended June 30, 2026. The company reported cash on hand of $8.3 million at quarter-end.
The biotechnology company continued IND-enabling work for EB-003 and reported additional preclinical data supporting its non-hallucinogenic profile. Enveric also completed a private placement generating approximately $5.0 million in upfront gross proceeds and raised about $1.5 million through warrant exercises.
- Second-quarter net loss was $3.0 million, compared with a $2.5 million net loss in the prior-year quarter.
- Basic and diluted loss per share was $0.76, compared with $11.65 a year earlier.
- Cash on hand totaled $8.3 million as of June 30, 2026.
- EB-003 development advanced through GloSensor assay results, photoreactivity testing and initiation of genotoxicity studies.
- Enveric received a Notice of Allowance for its EVM401 patent application and secured a U.S. patent for its EVM301 Series.
$ENVB Hedge Fund Activity
We have seen 13 institutional investors add shares of $ENVB stock to their portfolio, and 4 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SIO CAPITAL MANAGEMENT, LLC added 180,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $248,399
- RENAISSANCE TECHNOLOGIES LLC added 32,058 shares (+inf%) to their portfolio in Q2 2026, for an estimated $44,240
- BOOTHBAY FUND MANAGEMENT, LLC added 30,142 shares (+inf%) to their portfolio in Q2 2026, for an estimated $41,595
- GEODE CAPITAL MANAGEMENT, LLC removed 20,355 shares (-63.3%) from their portfolio in Q2 2026, for an estimated $28,089
- XTX TOPCO LTD added 18,990 shares (+inf%) to their portfolio in Q2 2026, for an estimated $26,206
- ADVISORSHARES INVESTMENTS LLC added 18,443 shares (+108.7%) to their portfolio in Q2 2026, for an estimated $25,451
- HRT FINANCIAL LP added 15,458 shares (+inf%) to their portfolio in Q2 2026, for an estimated $21,332
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
